333

PRECISION BIOSENSOR INC.

No trades
See on Supercharts

335810 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Precision Biosensor, Inc. engages in the provision of solutions for Point-of-care Testing (POCT) through the development and commercialization of biomarker diagnostic products. Its products include Exdia TRF Plus, an immunodiagnosis POCT platform that enhances sensitivity based on TRF technology, and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform that provides all-in-one diagnostic service based on multiplex technology. The company was founded on September 28, 2009 and is headquartered in Daejeon, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

335810 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company